Star Imaging and Path Lab logo

Star Imaging and Path Lab PE ratio, market cap and valuation

BSE: 544482Healthcare ServicesSmall Cap

Last close ₹74.70down ₹2.30 (2.99%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹77.00.

52-week range of traded prices to 23 Oct 2026
₹46.00Low, 30 Mar 2026₹152.00High, 14 Nov 2025
Market cap
₹130 Cr2,719th largest listed
P/E
6.7
P/B
1.1
Dividend yield
Nonein the last 12 months
ROE
16.6%
Debt to equity
0.18
Volume, BSE
5,000

Star Imaging and Path Lab PE ratio and valuation against its own history

Each ratio on 23 Oct 2026 beside its median over each window. The PE ratio is the market cap over the profit of the last twelve months.

  • Price to earnings6.75today
  • Price to book1.12today

    1 year, since Nov 2025

    Median 1.28

    Today is at or above 18% of the 232 days

  • Price to sales1.47today
  • EV to EBITDAA period of the last twelve months does not state its operating profit
  • Dividend yield0.00%today

    1 year

    Median 0.00%

    Today is at or above 100% of the 246 days

  • Earnings yield14.82%today

Each track ranks every trading day in the window from the day the ratio was lowest to the day it was highest; the dot is today. The share under it is how many of those days the ratio was at or below today's level, so a high share means today is higher than on most days in the window. A window is shown only when the ratio is held on most of its trading days; a day after a loss-making year has no P/E. Dividend yield is in per cent. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.

How each ratio is worked out, with today's figures

The twelve months: Filed 22 May

  • Price to earnings =Market cap÷Net profit, last twelve months₹19 Cr
  • Price to book =Market cap÷Net worth₹116 Cr
  • Price to sales =Market cap÷Revenue, last twelve months₹89 Cr
  • Enterprise value =Market cap+Borrowings₹21 Cr−Cash₹52 Cr
  • Market cap =Close×Shares in issue1,74,20,000at 30 Sep 2026

Consolidated accounts, the twelve months to Mar 2026, ₹ crore.Star Imaging and Path Lab financials ›

Star Imaging and Path Lab valuation at each year end

On the last trading day of each March, the month the company's year ends.

RatioMar 2026
Market cap (₹ crore)80.6
Price to earningsNo full year
Price to book0.8
Price to salesNo full year
EV to EBITDANo full year
Dividend yield0.00%
Earnings yieldNo full year
A ratio that does not exist on the day says why in its cell.

Star Imaging and Path Lab market cap, since Aug 2025

The last trading day of each month.

Market cap, ₹ crore

  • Market cap

Earnings per share, book value and enterprise value

From the close on 23 Oct 2026, with the last twelve months' results.

Enterprise value
₹99 Cr
Earnings per share
₹11.07
Book value per share
₹66.65
Dividends, last 12 months
None
Public's market cap
₹37 Cr

Against Healthcare Service Provider

36 listed companies in Healthcare Service Provider, each priced on its last trading day; Star Imaging and Path Lab is 16th among them by market cap. Each median leaves out Star Imaging and Path Lab itself and takes the other companies that have the figure.

Industry median P/E
20.6Across 17 other companies
Industry median P/B
1.6Across 29 other companies
Industry median EV/EBITDA
15.0Across 19 other companies
Industry median dividend yield
0.38%Across 9 other companies